Explore Global Companies & Account Intelligence

Comprehensive enterprise dossier available in global intelligence registry.

APEIRON Biologics is a privately held European biotech company based in Vienna, Austria, focused on the discovery and development of treatments for respiratory diseases and novel cancer immunotherapies. Our company has a well balanced portfolio with one product on the market and several promising products from clinical to pre-clinical stages. As for the product on the market, APEIRON received EU marketing approval for APN311 (Dinutuximab beta, Qarziba®) in May 2017 for the treatment of pediatric neuroblastoma patients. We out-licensed Qarziba® globally to EUSA Pharma Ltd, for which it holds exclusive rights to this product. APEIRON’s key projects and technologies are bolstered by a strong patent portfolio with broad territorial coverage. Our development expertise is validated through partnerships with leading global pharmaceutical companies and academic institutions.

APEIRON Biologics is a privately held European biotech company based in Vienna, Austria, focused on the discovery and development of treatments for respiratory diseases and novel cancer immunotherapies. Our company has a well balanced portfolio with one product on the market and several promising products from clinical to pre-clinical stages. As for the product on the market, APEIRON received EU marketing approval for APN311 (Dinutuximab beta, Qarziba®) in May 2017 for the treatment of pediatric neuroblastoma patients. We out-licensed Qarziba® globally to EUSA Pharma Ltd, for which it holds exclusive rights to this product. APEIRON’s key projects and technologies are bolstered by a strong patent portfolio with broad territorial coverage. Our development expertise is validated through partnerships with leading global pharmaceutical companies and academic institutions.

Apeiron Data Systems - Direct Scale-out Flash, inventor of NVMe™ over Ethernet (NOE) technology that delivers absolutely unmatched performance, scalability and simplification. Apeiron’s Direct Scale-out NVMe™ platform – is a game changer, the world’s only native NVMe™ storage platform to network 1,000's of standard NVMe SSDs & 100's of MIOPs. Apeiron is ready today for the next generation Intel® 3D XPoint™ technology. Follow us: @Apeiron_DS_Inc

Empowering Individuals, Small Start-Ups, and Large Business Enterprises to achieve Great Growth with Online Presence reaching Customers Globally. Get Known Globally with Our Brands! We cover up from Website Designing, Web Development, and Web Hosting to Email Marketing, our Brands will Deliver Services and Support to Individuals, Budding Startups, and Technology Enterprises to Ignite their online Presence and Connect customers Globally with Scopehosts, VPS9 Networks, Leasedlayer, Dotzo, TecoBytes, Modulesbasket, Resellbox, Debuglabs, and many more feature-rich brands. We have always believed in Winning the Future from 2008 and accustomed with Advancing Technology.

Impulsamos el crecimiento de tu empresa, digitalizando tus operaciones de TI y de servicio de atención al cliente, te ahorrará tiempo y dinero automatizando tus tareas con resultados efectivos.

Apeiron Mobility is developing fundamental technologies that are transforming sustainable transportation.

Unsere Leidenschaft ist die Systemgastronomie und deutschlandweit betreiben wir in Eigenregie oder im Franchising aktuell über 25 Restaurants in unterschiedlichen Konzepten. Täglich stellen wir uns begeistert der Aufgabe mit rund 1800 Kollegen mehr als 10.000 Gäste glücklich zu machen und immer wieder für uns zu gewinnen.

The mission of Apeiron Synthesis is to fully realize the potential of olefin metathesis in synthetic chemistry, with efficient and cost-effective solutions for R&D and commercial manufacturing processes – solutions that can benefit a wide range of industries, including agrichemicals, fine chemicals, flavor and fragrances, polymers and Pharma/Biopharma. Catalytic olefin metathesis technology offers chemists remarkable efficiency over traditional methods for building complex molecules - fewer synthetic steps and byproducts, reduced waste, and higher reaction concentrations - significantly lowering costs. Apeiron has developed a growing portfolio of over twenty high performance metathesis catalysts, available in milligram to multi-kilogram quantities, designed to accommodate a wide range of applications. With an uncompromising commitment to the design and use of robust new catalysts, our team of specialists is available to help customers transform their chemistry with metathesis technology. Olefin metathesis was discovered in the 1950’s as “olefin disproportionation”, with primarily industrial applications using harsh conditions. The first generations of homogeneous metathesis catalyses enabled transformations using relatively mild reaction conditions, with the potential to revolutionize the way chemists synthesize organic molecules – recognized as such with the 2005 Nobel Prize for Chemistry awarded to pioneers in the field. Apeiron is leading the way to diverse new applications to transform catalytic olefin metathesis from a technology with high potential to an important part of every chemist’s toolkit.

APEL International Inc. is a design company based out of 11201 Ampere Ct, Louisville, KY, United States.

Comprehensive enterprise dossier available in global intelligence registry.

Comprehensive enterprise dossier available in global intelligence registry.